Weiner, Michael
Flanagan, Mindy E.
Ernst, Katie
Cottingham, Ann H.
Rattray, Nicholas A.
Franks, Zamal
Savoy, April W.
Lee, Joy L.
Frankel, Richard M.
Article History
Received: 7 January 2024
Accepted: 27 June 2024
First Online: 18 July 2024
Declarations
:
: Informed consent was obtained from all participants. Ethics approval was obtained from the Indiana University Institutional Review Board. The study was conducted in accordance with the Declaration of Helsinki.
: Not applicable (IRB documents available upon request).
: Michael Weiner reports stock holdings in Allscripts Healthcare Solutions, Apple, Centene, DXC Technology, General Electric, Hewlett Packard, International Business Machines, Kyndryl Holdings, Micro Focus International, Microsoft, Oracle Cerner, Perkinelmer, Qualcomm, Walgreens, Zimmer Biomet, Intel, Cellcom Israel, Exact Sciences, IRhythm Technologies, Senseonics, Teladoc Health, and Varex Imaging. Remaining authors have no competing interest to declare.